EPIC Enzymes Pharmac. & Industrial (Delisted) financials and balance sheet

BSE: 524374

Last traded ₹1.71 on 15 Jan 2013

Delisted on 1 Dec 2017.

5 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.EPIC Enzymes Pharmac. & Industrial annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹6.50 Cr, year to Mar 2008A loss in 5 of the 5 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2012

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Depreciation0.0
  2. Other income0.0
  3. Finance costs0.0
  4. Profit before tax−0.2
  5. Net profit−0.2

Profit and loss

Standalone, ₹ crore, years to March.EPIC Enzymes Pharmac. & Industrial quarterly results

₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012
Revenue from operations6.51.50.10.2–
12.93.50.71.2–
Materials and goods bought5.51.10.50.1–
Operating profit before depreciation−6.4−2.1−0.6−1.0–
Operating margin−98.3%−138.9%−477.5%−458.6%–
Depreciation and amortisation0.60.40.40.10.0
Operating profit after depreciation−7.0−2.5−1.0−1.1–
Other income1.30.60.12.00.0
Finance costs3.10.30.34.60.0
Profit before one-off items and tax–−2.1−1.1−3.6−0.2
One-off items–––−10.4–
Profit before tax−8.9−2.1−1.1−14.0−0.2
Tax0.00.0–––
Net profit−8.9−2.1−1.1−14.0−0.2
Net margin−136.4%−144.4%−919.8%−6,318.9%–
Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2012: the statement does not state its revenue, which operating profit is worked out from, so operating profit is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2012
Earnings per share−₹0.18
Diluted earnings per share−₹0.18
Market cap at the year end (₹ crore)1.65

Ratios

Standalone, years to March.

RatioMar 2009Mar 2010Mar 2011Mar 2012
Revenue growth−77.2%−92.2%91.4%–
Interest cover is left blank for the years to Mar 2008, Mar 2009, Mar 2010 and Mar 2011: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2012.

Measure5 years3 years
Operating margin, average−293.3%−468.1%
Net margin, average−1,879.9%−3,619.4%